Achillion Pharmaceuticals celebrated on June 22 an expansion of its presence at its headquarters in New Haven, CT. Company leaders marked the occasion with a traditional ribbon cutting ceremony with representatives from the design and construction team, the city of New Haven and the state of Connecticut.

In addition to its growing footprint, Achillion plans to expand its workforce by approximately 20% in 2016, the second consecutive year the company has grown at this rate. According to the Connecticut Business and Industry Association, each job in the biopharma industry generates $652,033 in economic output, making the state-based biotech industry a key driver of economic growth.

Achillion press release
article in New Haven Register